Fluorouracil
| Internal ID | ede18837-1f8a-46dd-8024-74d583aef997 |
| Taxonomy | Organoheterocyclic compounds > Diazines > Pyrimidines and pyrimidine derivatives > Halopyrimidines |
| IUPAC Name | 5-fluoro-1H-pyrimidine-2,4-dione |
| SMILES (Canonical) | C1=C(C(=O)NC(=O)N1)F |
| SMILES (Isomeric) | C1=C(C(=O)NC(=O)N1)F |
| InChI | InChI=1S/C4H3FN2O2/c5-2-1-6-4(9)7-3(2)8/h1H,(H2,6,7,8,9) |
| InChI Key | GHASVSINZRGABV-UHFFFAOYSA-N |
| Popularity | 91,761 references in papers |
| Molecular Formula | C4H3FN2O2 |
| Molecular Weight | 130.08 g/mol |
| Exact Mass | 130.01785550 g/mol |
| Topological Polar Surface Area (TPSA) | 58.20 Ų |
| XlogP | -0.90 |
| Atomic LogP (AlogP) | -0.80 |
| H-Bond Acceptor | 2 |
| H-Bond Donor | 2 |
| Rotatable Bonds | 0 |
| fluorouracil |
| 51-21-8 |
| 5-FU |
| Fluoroplex |
| Efudex |
| Adrucil |
| Carac |
| Fluracil |
| 5-fluoropyrimidine-2,4(1H,3H)-dione |
| Fluoroblastin |
| There are more than 10 synonyms. If you wish to see them all click here. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.9866 | 98.66% |
| Caco-2 | - | 0.9115 | 91.15% |
| Blood Brain Barrier | + | 0.8500 | 85.00% |
| Human oral bioavailability | + | 0.6286 | 62.86% |
| Subcellular localzation | Mitochondria | 0.6099 | 60.99% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.9688 | 96.88% |
| OATP1B3 inhibitior | + | 0.9490 | 94.90% |
| MATE1 inhibitior | - | 1.0000 | 100.00% |
| OCT2 inhibitior | - | 0.9750 | 97.50% |
| BSEP inhibitior | - | 0.9598 | 95.98% |
| P-glycoprotein inhibitior | - | 0.9825 | 98.25% |
| P-glycoprotein substrate | - | 0.9788 | 97.88% |
| CYP3A4 substrate | - | 0.7933 | 79.33% |
| CYP2C9 substrate | - | 1.0000 | 100.00% |
| CYP2D6 substrate | - | 0.8777 | 87.77% |
| CYP3A4 inhibition | - | 0.9661 | 96.61% |
| CYP2C9 inhibition | - | 0.9658 | 96.58% |
| CYP2C19 inhibition | - | 0.9688 | 96.88% |
| CYP2D6 inhibition | - | 0.9361 | 93.61% |
| CYP1A2 inhibition | - | 0.9045 | 90.45% |
| CYP2C8 inhibition | - | 0.9882 | 98.82% |
| CYP inhibitory promiscuity | - | 0.9839 | 98.39% |
| UGT catelyzed | - | 0.0000 | 0.00% |
| Carcinogenicity (binary) | - | 0.8200 | 82.00% |
| Carcinogenicity (trinary) | Non-required | 0.7120 | 71.20% |
| Eye corrosion | - | 0.9835 | 98.35% |
| Eye irritation | + | 0.6907 | 69.07% |
| Skin irritation | - | 0.8760 | 87.60% |
| Skin corrosion | - | 0.9349 | 93.49% |
| Ames mutagenesis | - | 0.8500 | 85.00% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.7493 | 74.93% |
| Micronuclear | + | 0.9459 | 94.59% |
| Hepatotoxicity | + | 0.6500 | 65.00% |
| skin sensitisation | - | 0.8535 | 85.35% |
| Respiratory toxicity | + | 0.7889 | 78.89% |
| Reproductive toxicity | + | 0.8778 | 87.78% |
| Mitochondrial toxicity | + | 0.9250 | 92.50% |
| Nephrotoxicity | - | 0.6443 | 64.43% |
| Acute Oral Toxicity (c) | III | 0.4387 | 43.87% |
| Estrogen receptor binding | - | 0.9369 | 93.69% |
| Androgen receptor binding | - | 0.9004 | 90.04% |
| Thyroid receptor binding | - | 0.7894 | 78.94% |
| Glucocorticoid receptor binding | - | 0.9308 | 93.08% |
| Aromatase binding | - | 0.7928 | 79.28% |
| PPAR gamma | - | 0.9032 | 90.32% |
| Honey bee toxicity | - | 0.8467 | 84.67% |
| Biodegradation | - | 0.7000 | 70.00% |
| Crustacea aquatic toxicity | - | 0.5700 | 57.00% |
| Fish aquatic toxicity | - | 0.6926 | 69.26% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| CHEMBL3577 | P00352 | Aldehyde dehydrogenase 1A1 |
37650.5 nM |
Potency |
via CMAUP
|
| CHEMBL4331 | P68871 | Hemoglobin beta chain |
31622.8 nM 25118.9 nM 12589.3 nM |
Potency Potency Potency |
via CMAUP
via CMAUP via CMAUP |
| CHEMBL5514 | P42858 | Huntingtin |
1995.3 nM |
Potency |
via CMAUP
|
| CHEMBL1293224 | P10636 | Microtubule-associated protein tau |
5623.4 nM |
Potency |
via CMAUP
|
| CHEMBL1293298 | Q01453 | Peripheral myelin protein 22 |
4775.5 nM |
Potency |
via CMAUP
|
| CHEMBL1293235 | P02545 | Prelamin-A/C |
11.2 nM 11.2 nM 125.9 nM 158.5 nM |
Potency Potency Potency Potency |
via CMAUP
via Super-PRED via CMAUP via CMAUP |
| CHEMBL2842 | P42345 | Serine/threonine-protein kinase mTOR |
23280.9 nM |
Potency |
via CMAUP
|
| CHEMBL1293232 | Q16637 | Survival motor neuron protein |
631 nM 5011.9 nM 631 nM 11220.2 nM |
Potency Potency Potency Potency |
via Super-PRED
via CMAUP via CMAUP via CMAUP |
| CHEMBL1293256 | P40225 | Thrombopoietin |
12.6 nM 12.6 nM 12.6 nM |
Potency Potency Potency |
via CMAUP
via Super-PRED via CMAUP |
| CHEMBL1963 | P16473 | Thyroid stimulating hormone receptor |
794.3 nM 794.3 nM 794.3 nM |
Potency Potency Potency |
via Super-PRED
via CMAUP via CMAUP |
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL1937 | Q92769 | Histone deacetylase 2 | 90.14% | 94.75% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 89.53% | 98.59% |
| CHEMBL3038469 | P24941 | CDK2/Cyclin A | 88.29% | 91.38% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 85.81% | 83.82% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 85.53% | 95.56% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 85.27% | 93.03% |
| CHEMBL2535 | P11166 | Glucose transporter | 84.20% | 98.75% |
| CHEMBL4481 | P35228 | Nitric oxide synthase, inducible | 82.49% | 94.80% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 81.89% | 94.45% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 80.61% | 91.11% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| Alpinia roxburghii |
| Carpesium faberi |
| Morus cathayana |
| Patrinia scabra |